Nutex Health, Inc.

NASDAQ:NUTX

Medical - Healthcare Information Services

Healthcare
$172.74 +1.94%

+$2.84 today

Market cap
$1.19B
Beta
2.06
P/E (TTM)
10.4
EPS (TTM)
$14.38
52W Low $77.21High $193.07

Volume 0.16M

Average 0.17M

NUTX Pre-Tax Margin

Income before tax as a percentage of revenue.

Nutex Health, Inc.NASDAQ: NUTX

Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026

Pre-tax margin widens to 35.4%

Pre-tax margin was 35.4% in Q1 FY2026, up 5.7 pp from a year earlier. On a trailing-twelve-month basis it was 28.4%, up 0.8 pp year over year. Over 3 fiscal years it widened by 219.3 pp.

Context

  • Pre-tax margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
35.4%+18.3 pp QoQ
Last fiscal yearDec 2025
28.0%+5.1 pp YoY
LTMMar 2026
28.4%+0.8 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+5.7 pp——
1 year+5.1 pp——
3 years+219.3 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
28.0%
Year-over-year change
+5.1pp

Pre-Tax Margin vs competitors

How NUTX compares with its peers on the latest reported figures

  • NUTX's LTM Mar 2026 pre-tax margin of 28.4% is the highest of the 11 companies compared; the peer median is 3.6%.
  • Its year-over-year change of +0.8 pp is the 7th highest of 11, against a peer median of +0.9 pp.
  • Over three fiscal years its change of +219.3 pp compares with a peer median of -1.2 pp.
NUTX Competitors Peer median
Pre-Tax Margin for NUTX and competitors
Company Period LTM level YoY 3-year change
NUTXNutex Health, Inc.LTM Mar 202628.4% +0.8 pp+219.3 pp
THCTenet Healthcare CorporationLTM Jun 202617.7% +3.3 pp+6.1 pp
EHCEncompass Health CorporationLTM Jun 202616.6% +1.4 pp+5.7 pp
CONConcentra Group Holdings Parent, Inc.LTM Sep 202612.5% +2.3 pp-2.7 pp
UHSUniversal Health Services, Inc.LTM Jun 202611.2% +1.0 pp+4.9 pp
ARDTArdent Health Partners, LLCLTM Mar 20264.5% -1.9 pp-1.5 pp
SGRYSurgery Partners, Inc.LTM Sep 20262.7% -1.9 pp-0.8 pp
ASTHAstrana Health, Inc.LTM Mar 20261.4% -1.5 pp-6.3 pp
CYHCommunity Health Systems, Inc.LTM Mar 2026-1.0% +0.8 pp+2.9 pp
INNVInnovAge Holding Corp.LTM Mar 2026-2.2% +1.5 pp-2.9 pp
AGLAgilon Health, Inc.LTM Mar 2026-6.4% -2.2 pp-3.0 pp
Peer median (excluding NUTX) 3.6%+0.9 pp-1.2 pp

Competitors are the stored peer set for NUTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue331.53M219.29M247.65M479.95M875.26M
Cost of Revenue152.25M203.87M212.87M283.69M430.98M
Gross Profit179.28M15.42M34.77M196.26M444.28M
Gross Margin54.1%7.0%14.0%40.9%50.8%
Research & Development285.88K0000
Selling, General & Admin5.46M20M36.07M58.56M168.66M
Operating Expenses9.02M422.02M66.55M65.64M168.66M
Depreciation & Amortization7.76M13.13M17.59M18.97M20.53M
EBITDA183.45M(394.03M)(14.58M)148.65M287.54M
EBITDA Margin55.3%-179.7%-5.9%31.0%32.9%
Operating Income170.26M(406.6M)(31.77M)130.62M275.63M
Operating Margin51.4%-185.4%-12.8%27.2%31.5%
Interest Income00000
Interest Expense6.2M12.49M16.32M19.93M22.23M
Other Income / Expenses(773.88K)(13.05M)(16.72M)(20.87M)(30.84M)
Income Before Tax169.49M(419.65M)(48.49M)109.75M244.78M
Pre-Tax Margin51.1%-191.4%-19.6%22.9%28.0%
Income Tax Expense965.73K13.09M(5.07M)14.48M64.42M
Net Income132.59M(424.78M)(45.79M)52.18M70.79M
Net Margin40.0%-193.7%-18.5%10.9%8.1%
EPS (Basic)33.55(100.50)(10.39)10.2311.13
EPS (Diluted)33.55(100.36)(10.39)9.7110.48
Weighted Avg Shares4.02M4.23M4.41M5.1M6.36M
Weighted Avg Shares (Diluted)3.95M4.23M4.41M5.1M6.76M

Nutex Health, Inc.

NASDAQ:NUTX

Intrinsic Alpha fair value

Locked

Current Price

$172.74

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.